Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/302% below fair value
$27.39+0.43 (+1.59%)
Close on Nov 18, 2026Market cap $4.55BP/E –Yield –
Ionis Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Ionis Pharmaceuticals's pe ratio was 773.4× on Jan 31, 2023, against 29.2× a year earlier. Over the last 4 years it ranged from 5.6× to 791.3×, with a median of 50.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 773.4× | +40.7 |
| 2022 | Dec 30, 2022 | 732.7× | +638.8 |
| 2021 | Jan 29, 2021 | 93.9× | +5.5 |
| 2020 | Dec 31, 2020 | 88.3× | +68.2 |
| 2019 | Dec 31, 2019 | 20.1× | −266.7 |
| 2018 | Apr 30, 2018 | 286.9× | +77.3 |
| 2017 | Dec 29, 2017 | 209.6× | −179.7 |
| 2016 | Jan 29, 2016 | 389.3× | −230.0 |
| 2015 | Dec 31, 2015 | 619.3× | +612.5 |
| 2010 | Apr 30, 2010 | 6.8× | – |
See a number that looks wrong?